In another study, the beneficial effects of artemether against Aβ25–35-induced cognitive impairments in a rat model were correlated with the downregulation of the endogenous expressions of Aβ, BACE1, mTOR and tau proteins in N2a cells [83]. The gene discussed is MAPT; the disease is Cognitive impairment.